(redirected from Vasopeptidase Inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
See: deterrent
References in periodicals archive ?
The most promising novel class of products is the Vasopeptidase inhibitors, which will account for over half of the total sales of emerging products in 2006.
VANLEV, discovered by Bristol-Myers Squibb researchers, is the most clinically developed member of a new class of cardiovascular compounds known as vasopeptidase inhibitors (VPIs).
Omapatrilat is the most clinically advanced member of a class of cardiovascular drugs known as vasopeptidase inhibitors, that simultaneously inhibit neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE), two key enzymes that work together in the cardiovascular system to control heart function and blood pressure.